View More Recent Stories

Mar 5, 2025 07:00AM Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit
Feb 7, 2025 08:33AM Tonix Pharma (TNXP) Reports Prelim FY24 Results
Dec 23, 2024 08:01AM Tonix Pharma (TNXP) Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102
Dec 17, 2024 08:02AM Tonix Pharma (TNXP) Announces FDA Acceptance of the NDA for TNX-102
Nov 1, 2024 07:01AM Tonix Pharma (TNXP) Presented Data on Potential Mpox Vaccine TNX-801
Sep 27, 2024 07:00AM Tonix Pharma (TNXP) Issued US Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch to Treat Migraines
Sep 16, 2024 07:03AM Tonix Pharma (TNXP) Announces TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency
Sep 14, 2017 07:10AM Tonix Pharma (TNXP) Appoints Margaret Bell to Board
Sep 14, 2017 07:00AM Tonix Pharmaceuticals Elects Margaret Smith Bell to the Board of Directors
View More Recent Stories